1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Surgical Equipment Market Trends
  5. > Vascular Closure Devices Global Market – Forecast To 2022

Vascular Closure Devices Global Market – Forecast To 2022

  • February 2016
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 205 pages

Vascular closure is a procedure done for the closure of the punctured arterial wall after the performance of the catheterization procedure using the active and passive approximators. The active and passive approximators are the vascular closure device that reduce the blood loss with better haemostasis and reduce the time of ambulation with an increase the patient comfort. They are designed to provide quick and reliable haemostasis of access site after the invasive catheterization procedure.

They were introduced in the 1990’s to overcome the complications caused by the manual compression. The vascular closure global market is valued at $XX million in 2015 and expected to grow at a high single digit CAGR to reach $1,665.2 million by 2022. The vascular closure devices global market is segmented by product type, access, intervention and geography.

Increasing catheterization related procedures (PCI), preference for minimally-invasive solutions & rise in vascular procedures, ease in usage and quick hemostatic properties of VCDs, and increased utilization of transradial arterial access are driving the growth of the market.

High price of products, complications associated with VCD, less adoption of novel technologies in emerging countries are hampering the market of vascular closure. Reduced reimbursement, usage of animal related sources and lower revenue potential of VCD are threats for the market growth.

The vascular closure device global market by products is segmented into active approximators and passive approximators. Active approximators are sub-segmented into clips, plugs and suture mediated device. Plugs are further divided into FISH, collagen based and polymer based plugs. Active approximators hold the largest share in 2015 and are growing at a CAGR of 7.5% and passive approximators is expected to grow at high single digit CAGR by 2022.

The vascular closure devices global market by intervention is mainly segmented into diagnostics and intervention. The diagnostic vascular closure devices global market hold the largest share in 2015 and expected to grow at a highest CAGR of 8.7% and therapeutic vascular closure devices segment is expected to grow at a CAGR of XX% by 2022.

The vascular closure global market by access is mainly segmented into femoral access and radial access. The femoral vascular closure devices global market hold the largest share in 2015 and expected to reach $XX million in 2022, at a CAGR of XX% and radial vascular access segment is also expected to grow at a highest CAGR to reach $340.9 by 2022.

The vascular closure devices global market by geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest market share in 2015 and expected to reach $XX million by 2022, at high single digit CAGR due to increasing catheterization related procedures (PCI), preference for minimally-invasive solutions & rise in vascular procedures, ease in usage and quick hemostatic properties of VCDs and increased utilization of transradial arterial access. Europe region is expected to grow at a CAGR of XX% from 2015 to 2022 following the North American region.

Major players in the vascular closure market are Abbott Laboratories (U.S.), Advanced Vascular Dynamics (U.S.), B Braun Melsungen AG (Germany), Biotronik International (Germany), C R Bard (U.S.), Cardinal Health (U.S.), Cardiva Medical (U.S.), Morris Innovative (U.S.), Scion Biomedical (U.S.), St Jude Medical (U.S.), Terumo (Japan) and Vascular Solutions (U.S.).

Companies Mentioned

ABBOTT LABORATORIES
ADVANCED VASCULAR DYNAMICS
B.BRAUN MELSUNGEN AG
BIOTRONIK SE & CO. KG
C.R.BARD INC.
CARDINAL HEALTH, INC.
CARDIVA MEDICALS, INC.
MORRIS INNOVATIVE MEDICALS, CORP.
SCION BIOMEDICAL, INC.
ST.JUDE MEDICAL
TERUMO CORPORATION
VASCULAR SOLUTIONS INC.
LIST OF COMPANIES MENTIONED IN THE REPORT
ABBOTT LABORATORIES
ADVANCED VASCULAR DYNAMICA
ARSTASIS
B. BRAUN MELSUNGEN AG
BEIJING PUYI MEDICAL TECHNOLOGY CO., LTD
BENRIKAL SERVICES
BIOTRONIK CORPORATION
C.R. BARD INTERNATIONAL
CARDINAL HEALTH
CARDIODEX
CARDIVA MEDICAL
CP MEDICAL
CREGANNA MEDICAL
ENDOCOR GMBH
ESSENTIAL MEDICAL SUPPLIES
GAMBRO
HEM CON MEDICAL TECHNOLOGIES
HEMOBAND CORPORATION
INSEAL MEDICAL
LIAONING AIMU MEDICAL SCIENCE & TECHNOLOGY CO., LTD
MAQUET HOLDING B.V. & CO.KG
MARINE POLYMER TECHNOLOGIES
MEDEON BIODESIGN, INC
MORRIS INNOVATIVE INC
PRESSURE PRODUCT INC
SCION BIOMEDICAL
SEALANTIS
ST JUDES MEDICAL INC
TERUMO
TRANSLUMINAL TECHNOLOGIES, INC
TZ MEDICAL INC
VASCULAR CLOSURE SYSTEMS (CARDIOVASCULAR SYSTEMS)
VASCULAR INNOVATIONS CO LTD
VASCULAR SOLUTIONS
VIVASURE MEDICAL
W.L.GORE & ASSOCIATES
Z MEDICAL



Table Of Contents

Vascular Closure Devices Global Market - Forecast To 2022

1 EXECUTIVE SUMMARY 15
2 INTRODUCTION 21
2.1 KEY TAKE AWAYS 21
2.2 REPORT DESCRIPTION 21
2.3 MARKETS COVERED 23
2.4 STAKEHOLDERS 24
2.5 RESEARCH METHODOLOGY 24
2.5.1 MARKET SIZE ESTIMATION 25
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 28
2.5.3 SECONDARY SOURCES 29
2.5.4 PRIMARY SOURCES 30
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 30
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 31
2.5.7 ASSUMPTIONS 31
3 MARKET ANALYSIS 33
3.1 INTRODUCTION 33
3.2 MARKET SEGMENTATION 34
3.3 FACTORS INFLUENCING MARKET 36
3.3.1 DRIVERS AND OPPORTUNITIES 36
3.3.1.1 Increasing catheterization related procedures 36
3.3.1.2 Preference for minimally-invasive solutions 37
3.3.1.3 Ease in usage and quick hemostatic properties of VCDs 38
3.3.1.4 Increased utilization of transradial arterial access 38
3.3.2 RESTRAINTS AND THREATS 39
3.3.2.1 High price of products 39
3.3.2.2 Complications associated with VCD 39
3.3.2.3 Less adoption of novel technologies in emerging countries 40
3.3.2.4 Reduced reimbursement 40
3.3.2.5 Usage of animal related sources 41
3.3.2.6 Lower revenue potential of VCD 41
3.4 PORTER'S FIVE FORCE ANALYSIS 41
3.4.1 THREAT OF NEW ENTRANTS 42
3.4.2 THREAT OF SUBSTITUTES 42
3.4.3 BARGAINING POWER OF SUPPLIERS 44
3.4.4 BARGAINING POWER OF BUYERS 44
3.4.5 COMPETITIVE RIVALRY 44
3.5 REGULATORY AFFAIRS 45
3.5.1 U.S. 45
3.5.2 EUROPE 46
3.5.3 INDIA 46
3.5.4 CHINA 47
3.5.5 JAPAN 48
3.6 REIMBURSEMENT SCENARIO 49
3.6.1 TRANSCATHETER EMBOLIZATION OR OCCLUSION SERVICES 49
3.6.2 THROMBOLYSIS 51
3.6.3 DIAGNOSTIC CARDIAC CATHETERIZATION 51
3.6.4 INJECTION DIAGNOSTIC CARDIAC CATHETERIZATION 56
3.7 UPCOMING TECHNOLOGIES 58
3.8 SUPPLY CHAIN ANALYSIS 58
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 60
3.10 PATENT TRENDS 62
4 VASCULAR CLOSURE DEVICES GLOBAL MARKET, BY TYPE 64
4.1 INTRODUCTION 64
4.2 ACTIVE APPROXIMATORS 66
4.2.1 CLIPS 70
4.2.2 SUTURE MEDIATED DEVICES 72
4.2.3 PLUGS 73
4.2.3.1 Collagen based 75
4.2.3.2 Polymer based 76
4.2.3.3 FISH 78
4.3 PASSIVE APPROXIMATORS 79
4.3.1 HEMOSTATIC PADS/PATCHES 82
4.3.2 COMPRESSION DEVICES 84
5 VASCULAR CLOSURE DEVICES GLOBAL MARKET, BY INTERVENTION 86
5.1 INTRODUCTION 86
5.2 DIGNOSTICS 88
5.3 THERAPEUTICS 90
6 VASCULAR CLOSURE DEVICES GLOBAL MARKET, BY ACCESS 93
6.1 INTRODUCTION 93
6.2 FEMORAL ACCESS 95
6.3 RADIAL ACCESS 97
7 VASCULAR CLOSURE DEVICES GLOBAL MARKET, BY GEOGRAPHY 101
7.1 INTRODUCTION 101
7.2 NORTH AMERICA 102
7.3 EUROPE 108
7.4 ASIA PACIFIC 114
7.5 REST OF THE WORLD 119
8 COMPANY DEVELOPMENTS 126
8.1 INTRODUCTION 126
8.2 ACQUISITION AS A MAJOR GROWTH STRATEGY OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET PLAYERS 127
8.3 MERGERS AND ACQUISITION 127
8.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS and JOINT VENTURES 131
8.5 APPROVALS 134
8.6 BUSINESS EXPANSION 137
8.7 NEW PRODUCT LAUNCH 139
9 COMPANY PROFILES 141
9.1 ABBOTT LABORATORIES 141
9.1.1 OVERVIEW 141
9.1.2 FINANCIALS 142
9.1.3 PRODUCT PORTFOLIO 144
9.1.4 KEY DEVELOPMENTS 145
9.1.5 BUSINESS STRATEGY 146
9.1.6 SWOT ANALYSIS 147
9.2 ADVANCED VASCULAR DYNAMICS 148
9.2.1 OVERVIEW 148
9.2.2 FINANCIALS 148
9.2.3 PRODUCT PORTFOLIO 148
9.2.4 KEY DEVELOPMENTS 149
9.2.5 BUSINESS STRATEGY 149
9.2.6 SWOT ANALYSIS 150
9.3 B. BRAUN MELSUNGEN AG 151
9.3.1 OVERVIEW 151
9.3.2 FINANCIALS 152
9.3.3 PRODUCT PORTFOLIO 154
9.3.4 KEY DEVELOPMENTS 155
9.3.5 BUSINESS STRATEGY 156
9.3.6 SWOT ANALYSIS 157
9.4 BIOTRONIK SE and CO. KG 158
9.4.1 OVERVIEW 158
9.4.2 FINANCIALS 158
9.4.3 PRODUCT PORTFOLIO 158
9.4.4 KEY DEVELOPMENTS 159
9.4.5 BUSINESS STRATEGY 159
9.4.6 SWOT ANALYSIS 160
9.5 C.R.BARD INC. 161
9.5.1 OVERVIEW 161
9.5.2 FINANCIALS 162
9.5.3 PRODUCT PORTFOLIO 164
9.5.4 KEY DEVELOPMENTS 165
9.5.5 BUSINESS STRATEGY 166
9.5.6 SWOT ANALYSIS 167
9.6 CARDINAL HEALTH INC. 168
9.6.1 OVERVIEW 168
9.6.2 FINANCIALS 169
9.6.3 PRODUCT PORTFOLIO 171
9.6.4 KEY DEVELOPMENTS 172
9.6.5 BUSINESS STRATEGY 174
9.6.6 SWOT ANALYSIS 175
9.7 CARDIVA MEDICALS, INC. 176
9.7.1 OVERVIEW 176
9.7.2 FINANCIALS 176
9.7.3 PRODUCT PORTFOLIO 176
9.7.4 KEY DEVELOPMENTS 177
9.7.5 BUSINESS STRATEGY 177
9.7.6 SWOT ANALYSIS 178
9.8 MORRIS INNOVATIVE, INC. 179
9.8.1 OVERVIEW 179
9.8.2 FINANCIALS 179
9.8.3 PRODUCT PORTFOLIO 179
9.8.4 KEY DEVELOPMENTS 180
9.8.5 BUSINESS STRATEGY 180
9.8.6 SWOT ANALYSIS 181
9.9 SCION BIOMEDICALS, INC. 182
9.9.1 OVERVIEW 182
9.9.2 FINANCIALS 182
9.9.3 PRODUCT PORTFOLIO 182
9.9.4 KEY DEVELOPMENTS 183
9.9.5 BUSINESS STRATEGY 183
9.9.6 SWOT ANALYSIS 184
9.10 ST.JUDE MEDICAL 185
9.10.1 OVERVIEW 185
9.10.2 FINANCIALS 186
9.10.3 PRODUCT PORTFOLIO 188
9.10.4 KEY DEVELOPMENTS 189
9.10.5 BUSINESS STRATEGY 190
9.10.6 SWOT ANALYSIS 191
9.11 TERUMO CORPORATION 192
9.11.1 OVERVIEW 192
9.11.2 FINANCIALS 193
9.11.3 PRODUCT PORTFOLIO 195
9.11.4 KEY DEVELOPMENTS 196
9.11.5 BUSINESS STRATEGY 197
9.11.6 SWOT ANALYSIS 199
9.12 VASCULAR SOLUTIONS INC. 200
9.12.1 OVERVIEW 200
9.12.2 FINANCIALS 200
9.12.3 PRODUCT PORTFOLIO 202
9.12.4 KEY DEVELOPMENTS 203
9.12.5 BUSINESS STRATEGY 203
9.12.6 SWOT ANALYSIS 204


LIST OF TABLES

TABLE 1 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 18
TABLE 2 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 18
TABLE 3 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE,
BY INTERVENTION, (2014-2022) ($MN) 19
TABLE 4 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY ACCESS, (2014-2022) ($MN) 20
TABLE 5 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 66
TABLE 6 ACTIVE APPROXIMATOR GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 69
TABLE 7 ACTIVE APPROXIMATOR GLOBAL MARKET REVENUE, BY PRODUCT,
(2015-2022) ($MN) 70
TABLE 8 CLIPS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 71
TABLE 9 SUTURE MEDIATED DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 73
TABLE 10 PLUGS GLOBAL MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN) 74
TABLE 11 PLUGS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 75
TABLE 12 COLLAGEN BASED PLUGS GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 76
TABLE 13 POLYMER BASED PLUGS GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 78
TABLE 14 PASSIVE APPROXIMATOR GLOBAL MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 81
TABLE 15 PASSIVE APPROXIMATOR GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 82
TABLE 16 HEMOSTATIC PADS/PATCHES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 84
TABLE 17 COMPRESSION DEVICES GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 85
TABLE 18 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE,
BY INTERVENTION, (2014-2022) ($MN) 88
TABLE 19 DIAGNOSTICS VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 90
TABLE 20 THERAPEUTICS VASCULAR CLOSURE GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 92
TABLE 21 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY ACCESS, (2014-2022) ($MN) 95
TABLE 22 FEMORAL VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 97
TABLE 23 RADIAL VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 100
TABLE 24 NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET REVENUE,
BY TYPE, (2014-2022) ($MN) 105
TABLE 25 NORTH AMERICAN ACTIVE APPROXIMATOR MARKET REVENUE,
BY PRODUCT, (2014-2022) ($MN) 105
TABLE 26 NORTH AMERICAN PLUGS MARKET REVENUE, BY MATERIAL,
(2014-2022) ($MN) 106
TABLE 27 NORTH AMERICAN PASSIVE APPROXIMATOR MARKET REVENUE,
BY PRODUCT, (2014-2022) ($MN) 106
TABLE 28 NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET REVENUE,
BY INTERVENTION, (2014-2022) ($MN) 107
TABLE 29 NORTH AMERICAN VASCULAR CLOSURE DEVICE MARKET REVENUE,
BY ACCESS, (2014-2022) ($MN) 107
TABLE 30 EUROPEAN VASCULAR CLOSURE DEVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 110
TABLE 31 EUROPEAN ACTIVE APPROXIMATOR MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 111
TABLE 32 EUROPEAN PLUGS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN) 111
TABLE 33 EUROPEAN PASSIVE APPROXIMATOR MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 112
TABLE 34 EUROPEAN VASCULAR CLOSURE DEVICES MARKET REVENUE,
BY INTERVENTION, (2014-2022) ($MN) 113
TABLE 35 EUROPEAN VASCULAR CLOSURE DEVICES MARKET REVENUE, BY ACCESS, (2014-2022) ($MN) 113
TABLE 36 ASIA-PACIFIC VASCULAR CLOSURE DEVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 116
TABLE 37 ASIA-PACIFIC ACTIVE APPROXIMATOR MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 116
TABLE 38 ASIA-PACIFIC PLUGS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN) 117
TABLE 39 ASIA-PACIFIC PASSIVE APPROXIMATOR MARKET REVENUE, BY PRODCUT, (2014-2022) ($MN) 118
TABLE 40 ASIA-PACIFIC VASCULAR CLOSURE DEVICES MARKET REVENUE,
BY INTERVENTION, (2014-2022) ($MN) 118
TABLE 41 ASIA-PACIFIC VASCULAR CLOSURE DEVICES MARKET REVENUE,
BY ACCESS, (2014-2022) ($MN) 119
TABLE 42 ROW VASCULAR CLOSURE DEVICES MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 122
TABLE 43 ROW ACTIVE APPROXIMATOR MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 123
TABLE 44 ROW PLUGS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN) 123
TABLE 45 ROW PASSIVE APPROXIMATOR MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 124
TABLE 46 ROW VASCULAR CLOSURE DEVICES MARKET REVENUE, BY INTERVENTION, (2014-2022) ($MN) 124
TABLE 47 ROW VASCULAR CLOSURE DEVICES MARKET REVENUE, BY ACCESS,
(2014-2022) ($MN) 125
TABLE 48 MERGERS AND ACQUISITION (2011-2015) 128
TABLE 49 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES (2012-2015) 132
TABLE 50 APPROVALS (2011-2015) 135
TABLE 51 BUSINESS EXPANSION (2011-2015) 137
TABLE 52 NEW PRODUCT LAUNCH (2011-2015) 139



TABLE 53 ABBOTT LABORATORIES: TOTAL REVENUE AND RandD EXPENSES,
(2013-2015) ($MN) 142
TABLE 54 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN) 143
TABLE 55 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 144
TABLE 56 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 152
TABLE 57 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENT,
(2012-2014) ($MN) 153
TABLE 58 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 154
TABLE 59 C.R.BARD INC.: TOTAL REVENUE AND RandD EXPENSES (2013-2015) ($MN) 162
TABLE 60 C.R.BARD INC: TOTAL REVENUE, BY SEGMENT, (2013-15) ($MN) 163
TABLE 61 C.R.BARD INC: TOTAL REVENUE, BY REGION, (2013-15) ($MN) 164
TABLE 62 CARDINAL HEALTH, INC.: TOTAL REVENUE AND OPERATING EXPENSES, (2013-2015) ($MN) 169
TABLE 63 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY SEGMENT,
(2013-2015) ($MN) 170
TABLE 64 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 171
TABLE 65 ST JUDE MEDICAL: TOTAL REVENUE AND RandD EXPENSES,
(2013-2015) ($MN) 186
TABLE 66 ST JUDE MEDICAL : TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN) 187
TABLE 67 ST.JUDE INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 188
TABLE 68 TERUMO CORPORATION: TOTAL REVENUE AND RandD EXPENSES,
(2013-2015) ($MN) 193
TABLE 69 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS,
(2013-2015) ($MN) 194
TABLE 70 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 195
TABLE 71 VASCULAR SOLUTIONS INC.: TOTAL REVENUE AND RandD EXPENSES, (2013-2015) ($MN) 200
TABLE 72 VASCULAR SOLUTIONS INC.: TOTAL REVENUE, BY SEGMENT,
(2013-2015) ($MN) 201
TABLE 73 VASCULAR SOLUTIONS INC.: TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 202







LIST OF FIGURES

FIGURE 1 VASCULAR CLOSURE DEVICE GLOBAL MARKET SHARE, BY GEOGRAPHY, (2014-22) ($MN) 17
FIGURE 2 RESEARCH METHODOLOGY: VASCULAR CLOSURE DEVICES MARKET 25
FIGURE 3 VASCULAR CLOSURE DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 26
FIGURE 4 VASCULAR CLOSURE DEVICES MARKET: FORECASTING MODEL 27
FIGURE 5 VASCULAR CLOSURE DEVICES MARKET: MARKET CRACHDOWN AND DATA TRIANGULATION 28
FIGURE 6 VASCULAR CLOSURE DEVICES MARKET: MARKET SEGMENTATION 34
FIGURE 7 MARKET DYNAMICS 36
FIGURE 8 VASCULAR CLOSURE DEVICES MARKET: PORTER'S ANALYSIS 43
FIGURE 9 VASCULAR CLOSURE DEVICE MARKET: SUPPLY CHAIN ANALYSIS 59
FIGURE 10 VASCULAR CLOSURE DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%) 60
FIGURE 11 VASCULAR CLOSURE DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2015) 63
FIGURE 12 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 65
FIGURE 13 ACTIVE APPROXIMATOR GLOBAL MARKET REVENUE, BY PRODUCT, 2015, ($MN) 68
FIGURE 14 PASSIVE APPROXIMATOR GLOBAL MARKET REVENUE, BY PRODUCT,
(2014-2022), ($MN) 80
FIGURE 15 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE,
BY INTERVENTION, (2014-22) ($MN) 87
FIGURE 16 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY ACCESS, (2015 V'S 2022) ($MN) 94
FIGURE 17 RADIAL ACCESS DEVICES GLOBAL MARKET SHARE, BY REGION, 2015, (%) 99
FIGURE 18 VASCULAR CLOSURE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) (CAGR %) 102
FIGURE 19 NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET REVENUE,
BY TYPE, INTERVENTION and ACCESS, (2015 V'S 2022) ($MN) 104
FIGURE 20 EUROPEAN VASCULAR CLOSURE DEVICES MARKET REVENUE, BY TYPE, INTERVENTION and ACCESS, (2015 V'S 2022) ($MN) 109
FIGURE 21 ASIA-PACIFIC VASCULAR CLOSURE DEVICES MARKET REVENUE, BY TYPE, INTERVENTION and ACCESS, (2015 V'S 2022) ($MN) 115
FIGURE 22 ROW VASCULAR CLOSURE DEVICES MARKET REVENUE, BY TYPE, INTERVENTION and ACCESS, (2015 V'S 2022) ($MN) 121
FIGURE 23 KEY GROWTH STRATEGIES (2012-2015) 126
FIGURE 24 SWOT: ABBOTT LABORATORIES 147
FIGURE 25 SWOT: ADVANCED VASCULAR DYNAMICS 150
FIGURE 26 SWOT: B.BRAUN MELSUNGEN AG 157
FIGURE 27 SWOT: BIOTRONIK SE and CO. KG 160
FIGURE 28 SWOT: C.R.BARD INC. 167
FIGURE 29 SWOT: CARDINAL HEALTH, INC. 175
FIGURE 30 SWOT: CARDIVA MEDICALS, INC. 178
FIGURE 31 SWOT: MORRIS INNOVATIVE MEDICALS, CORP. 181
FIGURE 32 SWOT: SCION BIOMEDICAL, INC. 184
FIGURE 33 SWOT: ST.JUDE MEDICAL 191
FIGURE 34 SWOT: TERUMO CORPORATION 199
FIGURE 35 SWOT: VASCULAR SOLUTIONS INC. 204

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Cardiovascular Surgical Devices Market Analysis & Trends – Surgical Devices (Cardiac Ablation Devices), Cardiac Rhythm Management Devices, Diagnostic and Monitoring Devices, Technology - Forecast to 2025

Global Cardiovascular Surgical Devices Market Analysis & Trends – Surgical Devices (Cardiac Ablation Devices), Cardiac Rhythm Management Devices, Diagnostic and Monitoring Devices, Technology - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Cardiovascular Surgical Devices Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $96.5 billion by 2025. Some of the prominent trends that the market ...

Global Vascular Closure Devices Market 2016-2020

Global Vascular Closure Devices Market 2016-2020

  • $ 2500
  • Industry report
  • July 2016
  • by Infiniti Research Limited

About the Vascular Closure Devices Market The global vascular closure devices market is likely to grow at a steady pace during the forecast period. This is because many clinical studies regarding vascula ...

Global Cardiovascular Surgical Equipment Industry 2016 Market Research Report

Global Cardiovascular Surgical Equipment Industry 2016 Market Research Report

  • $ 2850
  • Industry report
  • June 2016
  • by 9Dimen Research

2016 Global Cardiovascular Surgical Equipment Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cardiovascular Surgical Equipment industry, ...


Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

Cardiology

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.